Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
Express Pharma
Lupin launches Raltegravir Tablets USP, 600 mg in the US
The product has received US FDA approval and is eligible for 180-day generic drug exclusivity The post Lupin launches Raltegravir Tablets USP, 600 mg in the US appeared first on Express Pharma.
Read Full Article
Express Pharma
Lupin appoints Akhil Gupta as Independent Director to its Board
The appointment brings over four decades of experience in business development, corporate strategy, finance, governance and mergers and acquisitions to the Board The post Lupin appoints Akhil Gupta as Independent Director to its Board appeared first on Express Pharma.
Read Full Article
Express Pharma
India’s life sciences and healthcare sectors raise $173m in October 2026
The sectors recorded 19 funding rounds during the month, with funding rising 6.91 per cent year on year and falling 7.35 per cent from September 2026 The post India’s life sciences and healthcare sectors raise $173m in October 2026 appeared first on Express Pharma.
Read Full Article
Express Pharma
Shilpa CDMO invests $50 million to expand peptide manufacturing capacity
The expansion will add 10 KL of SPPS reactor capacity and establish six parallel cGMP manufacturing lines to support peptide development and commercial supply The post Shilpa CDMO invests $50 million to expand peptide manufacturing capacity appeared first on Express Pharma.
Read Full Article
Pharma Tech
FDA calls for stronger potency upkeep in CGT manufacturing
The FDA’s CBER director said patients should have assurance that administered products will work as intended.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
PharmaShots
Nov 4, 2026, 8:10 AM
CStone Pharmaceuticals Partners with Kimia Therapeutics to Advance a DDR Inhibitor
Shots: Ref: PRnewswire |  Image: CStone & Kimia  | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post CStone Pharmaceuticals Partners with Kimia Therapeutics to Advance a DDR Inhibitor appeared first on PharmaShots.
PharmaShots
Nov 4, 2026, 7:45 AM
Nurix Therapeutics Reports Sanofi’s Decision to Discontinue Phase 1 Development of STAT6 Degrader SAR448272
Shots: Ref: Globenewswire |  Image: Nurix Therapeutics & Sanofi’s | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Nurix Therapeutics Reports Sanofi’s Decision to Discontinue Phase 1 Development of STAT6 Degrader SAR448272 appeared first on PharmaShots.
ET Pharma
Nov 4, 2026, 6:44 AM
AbbVie expands Oxford R&D facility as part of ÂŁ120 million-plus investment
The investment comes a few months after the US and Britain finalised an agreement aimed at increasing UK medicine prices in line with President Donald Trump's new US pricing policies.
PharmaShots
Nov 4, 2026, 6:36 AM
Novartis Terminates Option, Collaboration and License Agreement with BioArctic for BrainTransporter Technology
Shots: Novartis has notified BioArctic of its decision to terminate their Aug 2025 option, collaboration & license agreement to explore a treatment combining BioArctic’s BrainTransporter technology with an undisclosed Novartis antibody The termination follows Novartis’ decision to discontinue the program & is unrelated to the BrainTransporter technology; BioArctic will retain the full 30M upfront &… The post Novartis Terminates Option, Collaboration and License Agreement with BioArctic for BrainTransporter Technology appeared first on PharmaShots.
Express Pharma
Nov 4, 2026, 6:23 AM
Lupin launches Raltegravir Tablets USP, 600 mg in the US
The product has received US FDA approval and is eligible for 180-day generic drug exclusivity The post Lupin launches Raltegravir Tablets USP, 600 mg in the US appeared first on Express Pharma.
Express Pharma
Nov 4, 2026, 6:00 AM
Lupin appoints Akhil Gupta as Independent Director to its Board
The appointment brings over four decades of experience in business development, corporate strategy, finance, governance and mergers and acquisitions to the Board The post Lupin appoints Akhil Gupta as Independent Director to its Board appeared first on Express Pharma.
News
Latest industry coverage
Google News
Nov 4, 2026, 8:00 AM
ARTHEx Biotech Appoints Christian Freitag, M.D., as Chief Medical Officer - PR Newswire
ARTHEx Biotech Appoints Christian Freitag, M.D., as Chief Medical Officer  PR Newswire
Google News
Nov 4, 2026, 7:30 AM
Biotech Growth Trust Positioned To Benefit From Sector Recovery: Kepler - DirectorsTalk Interviews
Biotech Growth Trust Positioned To Benefit From Sector Recovery: Kepler  DirectorsTalk Interviews
Google News
Nov 4, 2026, 7:10 AM
Rhythm Pharmaceuticals (RYTM) Dropped, So What Is Behind The Fresh Attention? - Yahoo Finance
Rhythm Pharmaceuticals (RYTM) Dropped, So What Is Behind The Fresh Attention?  Yahoo Finance
Google News
Nov 4, 2026, 7:06 AM
Novo Nordisk's CFO Karsten Munk Knudsen to leave company - Reuters
Novo Nordisk's CFO Karsten Munk Knudsen to leave company  Reuters
Google News
Nov 4, 2026, 7:05 AM
The CDMO partner for next-gen medicine - European Biotechnology Magazine
The CDMO partner for next-gen medicine  European Biotechnology Magazine
Google News
Nov 4, 2026, 7:03 AM
Theon Group Acquires Maneesh Pharma’s Unit VI In Baddi, Renames It Zoevita Lifesciences - Business Connect India
Theon Group Acquires Maneesh Pharma’s Unit VI In Baddi, Renames It Zoevita Lifesciences  Business Connect India
Google News
Nov 4, 2026, 6:55 AM
“For Indian CDMOs, the opportunity is to build depth rather than pursue growth through capacity alone” - BioSpectrum India
“For Indian CDMOs, the opportunity is to build depth rather than pursue growth through capacity alone”  BioSpectrum India
Google News
Nov 4, 2026, 6:43 AM
Biocon Malaysia Recognised Across Five Categories at MOPI Pharma Industry Awards 2026 - The Manila Times
Biocon Malaysia Recognised Across Five Categories at MOPI Pharma Industry Awards 2026Â Â The Manila Times
Google News
Nov 4, 2026, 6:36 AM
Novo Nordisk raises 2026 outlook as Wegovy pill beats forecasts - Reuters
Novo Nordisk raises 2026 outlook as Wegovy pill beats forecasts  Reuters
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer